Rhabdomyosarcoma in Pediatric Patients Under 2 Years: Clinical Features and Outcome
Children under 2 years of age with RMS face significant challenges, with high local recurrence rates and suboptimal survival outcomes compared with older pediatric patients. Our findings highlight the need for tailored treatment approaches that balance effective local control with minimizing long-term toxicity.
Authors
- Mohammad Boheisi
- Hadeel Halalsheh (ORCID: https://orcid.org/0000-0003-4803-1976)
- Nada Odeh (ORCID: https://orcid.org/0009-0009-2422-4061)
- Ahmad Kh. Ibrahimi (ORCID: https://orcid.org/0000-0001-6256-861X)
- Mohammad Alzoubi (ORCID: https://orcid.org/0000-0003-3268-7938)
- Iyad Sultan
- Adam Diab
- Shrouq Amer
- Raghad Darweesh
- Noor Al-Assaf
Institutions
- University of Jordan (JO)
- Pediatric Oncology Group (CA)
- King Hussein Cancer Center (JO)
- Radiation Oncology Associates (US)
- Indiana University School of Medicine
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1097/mph.0000000000003124
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00